Skip to main content

Advances in Clinical Chemistry

  • 1st Edition, Volume 134 - October 1, 2026
  • Latest edition
  • Editor: Gregory S. Makowski
  • Language: English

The ACC series examines physiologic and pathophysiologic biochemistry and impact thereof on Clinical Chemistry testing and design. Molecular mechanisms of disease processes are… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

The ACC series examines physiologic and pathophysiologic biochemistry and impact thereof on Clinical Chemistry testing and design. Molecular mechanisms of disease processes are highlighted in the context of traditional, current and emerging technologies. Advances in the development of improved diagnostic and predictive biomarkers are examined especially those targeting early and emerging diseases. These evolving technologies and analytic strategies have become increasing relevant given the healthcare and socioeconomic impact worldwide.

Key features

  • Omics of heart failure and use of AI to refine personalized medicine and risk stratification
  • MicroRNAs as diagnostic and prognostic biomarkers in CVD
  • Strategies in antidoping detection of pseudo-endogenous drugs

Readership

Clinical Laboratory Professionals and Scientists; Physicians; Post-Doctoral Fellows; Research Scientists

Table of contents

Preface

1. Biomarkers in Heart Failure
Alberto Aimo

2. RNA biomarkers in antidoping
Olivier Salamin

3. Cardiovascular disease and miRNA
Md Sayed Ali Sheikh

4. Chronic low-grade inflammation in vegetarians and vegans: biomarker evidence and methodological considerations
Goran Gajski

5. Advances in microfluidic extracellular vesicle technology
Sebastian Schwaminger

6. Biomarkers for Assessing Magnesium Status
Lusliany J Rondón

Product details

  • Edition: 1
  • Latest edition
  • Volume: 134
  • Published: October 1, 2026
  • Language: English

About the editor

GM

Gregory S. Makowski

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA